Skip to main content

Featured

Fed Poised for Rate Cut, Signals Limited Easing Ahead

                                                          US Federal Reserve Chair Jerome Powell The Federal Reserve is widely expected to cut interest rates at its upcoming meeting, marking a shift in monetary policy aimed at supporting economic growth amid cooling inflation and slowing demand. While markets have anticipated a series of reductions, policymakers appear cautious, with signals suggesting only one additional cut may be on the horizon for next year. This measured approach reflects the Fed’s balancing act: easing financial conditions to sustain momentum while avoiding overstimulation that could reignite price pressures. Investors are closely watching the central bank’s language for clues on the trajectory of borrowing costs, as households and businesses continue to navigate a delicate economic environment....
Post a Comment
Read more

article

Labels

Pharmacare in Canada: A Dream or a Reality?

 


The fate of Canada's pharmacare plan is uncertain as the federal government faces challenges in implementing a universal drug coverage program, even if a bill to create one passes in Parliament. Bill C-213, the Canada Pharmacare Act, aims to establish a national framework for pharmacare that would ensure all Canadians have access to prescription drugs based on their medical needs, not their ability to pay. 

However, the bill does not specify how the program would be funded, administered or negotiated with the provinces and territories, leaving many questions unanswered about the feasibility and cost-effectiveness of pharmacare. Some experts and stakeholders have expressed doubts about whether Ottawa has the political will, the constitutional authority and the fiscal capacity to deliver on its promise of pharmacare, especially in the wake of the COVID-19 pandemic that has strained the health care system and the public purse.

Labels:

Comments

Post a Comment